IndUced Pluripotent Stem Cells Model Personalized Variations in Liver Disease Resulting From α1-Antitrypsin Deficiency

Hepatology

Volumn 62, Issue 1, 2015, Pages 147-157

  Tafaleng, Edgar N ^a,b   Chakraborty, Souvik ^a,b   Han, Bing ^a,b   Hale, Pamela ^a,b   Wu, Wanquan ^a,b   Soto Gutierrez, Alejandro ^a,b,c   Feghali Bostwick, Carol A ^d   Wilson, Andrew A ^e   Kotton, Darrell N ^e   Nagaya, Masaki ^a,c   Strom, Stephen C ^f   Roy Chowdhury, Jayanta ^g   Stolz, Donna B ^a   Perlmutter, David H ^a,b   Fox, Ira J ^a,b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^f KAROLINSKA INSTITUTE   (Sweden)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA FETOPROTEIN; ASIALOGLYCOPROTEIN RECEPTOR; ENDOGLYCOSIDASE H; GLYCOSIDASE; UNCLASSIFIED DRUG;

ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; BIOACCUMULATION; CELL DIFFERENTIATION; CELL INCLUSION; CELL LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; HUMAN; HUMAN CELL; LIVER CELL; LIVER DISEASE; LIVER FUNCTION; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN HOMEOSTASIS; PROTEIN PROCESSING; RIBOSOME; ROUGH ENDOPLASMIC RETICULUM; TRANSMISSION ELECTRON MICROSCOPY; CELL CULTURE; COMPLICATION; INDUCED PLURIPOTENT STEM CELL; LIVER DISEASES; METABOLISM;

ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; CELLS, CULTURED; ENDOPLASMIC RETICULUM, ROUGH; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LIVER DISEASES;

EID: 84933178811     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27753     Document Type: Article

References (32)

1. Chan S, Rees D. Molecular basis for the alpha1-protease inhibitor deficiency. Nature 1975;255:240-241.
2. Carrell R, Jeppsson J, Laurell C, Brennan S, Owen M, Vaughan L, Boswell D. Structure and variation of human alpha 1-antitrypsin. Nature 1982;298:329-334.
3. Perlmutter D, Cole F, Kilbridge P, Rossing T, Colten H. Expression of the alpha 1-proteinase inhibitor gene in human monocytes and macrophages. Proc Natl Acad Sci U S A 1985;82:795-799.
4. Perlmutter DH, Silverman GA. Hepatic fibrosis and carcinogenesis in alpha1-antitrypsin deficiency: a prototype for chronic tissue damage in gain-of-function disorders. Cold Spring Harb Perspect Biol 2011;3: a005801.
5. Nelson D, Teckman J, Di Bisceglie A, Brenner D. Diagnosis and management of patients with α1-antitrypsin (A1AT) deficiency. Clin Gastroenterol Hepatol 2012;10:575-580.
6. Wu Y, Whitman I, Molmenti E, Moore K, Hippenmeyer P, Perlmutter D. A lag in intracellular degradation of mutant alpha 1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ alpha 1-antitrypsin deficiency. Proc Natl Acad Sci U S A 1994;91:9014-9018.
7. Hidvegi T, Ewing M, Hale P, Dippold C, Beckett C, Kemp C, et al. An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis. Science 2010;329:229-232.
8. Li J, Pak SC, O'Reilly LP, Benson JA, Wang Y, Hidvegi T, et al. Fluphenazine reduces proteotoxicity in C. elegans and mammalian models of alpha-1-antitrypsin deficiency. PLoS One 2014;9:e87260.
9. Gosai SJ, Kwak JH, Luke CJ, Long OS, King DE, Kovatch KJ, et al. Automated high-content live animal drug screening using C. elegans expressing the aggregation prone serpin α1-antitrypsin Z. PloS One 2010;5:e15460.
10. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-872.
11. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917-1920.
12. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008;26:101-106.
13. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin, II, Thomson JA. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009;324:797-801.
14. Basma H, Soto-Gutierrez A, Yannam GR, Liu L, Ito R, Yamamoto T, et al. Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology 2009;136:990-999.
15. Song Z, Cai J, Liu Y, Zhao D, Yong J, Duo S, et al. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res 2009;19:1233-1242.
16. Si-Tayeb K, Noto FK, Nagaoka M, Li J, Battle MA, Duris C, et al. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 2010;51:297-305.
17. Rashid ST, Corbineau S, Hannan N, Marciniak SJ, Miranda E, Alexander G, et al. Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J Clin Invest 2010;120:3127-3136.
18. Yusa K, Rashid ST, Strick-Marchand H, Varela I, Liu PQ, Paschon DE, et al. Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells. Nature 2011;478:391-394.
19. Choi SM, Kim Y, Shim JS, Park JT, Wang RH, Leach SD, et al. Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells. Hepatology 2013;57:2458-2468.
20. Eggenschwiler R, Loya K, Wu G, Sharma AD, Sgodda M, Zychlinski D, et al. Sustained knockdown of a disease-causing gene in patient-specific induced pluripotent stem cells using lentiviral vector-based gene therapy. Stem Cells Transl Med 2013;2:641-654.
21. Cayo MA, Cai J, DeLaForest A, Noto FK, Nagaoka M, Clark BS, et al. JD induced pluripotent stem cell-derived hepatocytes faithfully recapitulate the pathophysiology of familial hypercholesterolemia. Hepatology 2012;56:2163-2171.
22. Leung A, Nah SK, Reid W, Ebata A, Koch CM, Monti S, et al. Induced pluripotent stem cell modeling of multisystemic, hereditary transthyretin amyloidosis. Stem Cell Reports 2012;1:451-463.
23. Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, et al. A more efficient method to generate integration-free human iPS cells. Nat Methods 2011;8:409-412.
24. Somers A, Jean JC, Sommer C, Omari A, Ford C, Mills J, et al. Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. Stem Cells 2010;28:1728-1740.
25. Schneider C, Rasband W, Eliceiri K. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012;9:671-675.
26. Perlmutter DH, Kay RM, Cole FS, Rossing TH, Van Thiel D, Colten HR. The cellular defect in alpha 1-proteinase inhibitor (alpha 1-PI) deficiency is expressed in human monocytes and in Xenopus oocytes injected with human liver mRNA. Proc Natl Acad Sci U S A 1985;82:6918-6921.
27. Teckman JH, Burrows J, Hidvegi T, Schmidt B, Hale PD, Perlmutter DH. The proteasome participates in degradation of mutant alpha 1-antitrypsin Z in the endoplasmic reticulum of hepatoma-derived hepatocytes. J Biol Chem 2001;276:44865-44872.
28. Yunis E, Agostini R, Glew R. Fine structural observations of the liver in alpha-1-antitrypsin deficiency. Am J Pathol 1976;82:265-286.
29. Hultcrantz R, Mengarelli S. Ultrastructural liver pathology in patients with minimal liver disease and alpha 1-antitrypsin deficiency: a comparison between heterozygous and homozygous patients. Hepatology 1983;4:937-945.
30. Miranda E, Pérez J, Ekeowa UI, Hadzic N, Kalsheker N, Gooptu B, et al. A novel monoclonal antibody to characterize pathogenic polymers in liver disease associated with alpha1-antitrypsin deficiency. Hepatology 2010;52:1078-1088.
31. Wolff S, Weissman J, Dillin A. Differential scales of protein quality control. Cell 2014;157:52-64.
32. Balch W, Morimoto R, Dillin A, Kelly J. Adapting proteostasis for disease intervention. Science 2008;319:916-919.